Is TATACHEM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TATACHEM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TATACHEM (₹1111.75) is trading above our estimate of fair value (₹596.36)
Significantly Below Fair Value: TATACHEM is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TATACHEM?
Key metric: As TATACHEM is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for TATACHEM. This is calculated by dividing TATACHEM's market cap by their current
revenue.
What is TATACHEM's PS Ratio?
PS Ratio
1.9x
Sales
₹149.93b
Market Cap
₹283.11b
TATACHEM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue
2.3x
Enterprise Value/EBITDA
15.3x
PEG Ratio
n/a
Price to Sales Ratio vs Peers
How does TATACHEM's PS Ratio compare to its peers?
Price-To-Sales vs Industry: TATACHEM is expensive based on its Price-To-Sales Ratio (1.9x) compared to the Indian Chemicals industry average (1.8x).
Price to Sales Ratio vs Fair Ratio
What is TATACHEM's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
TATACHEM PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
1.9x
Fair PS Ratio
4.5x
Price-To-Sales vs Fair Ratio: TATACHEM is good value based on its Price-To-Sales Ratio (1.9x) compared to the estimated Fair Price-To-Sales Ratio (4.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst TATACHEM forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
₹1,111.75
₹936.38
-15.8%
9.5%
₹1,070.00
₹820.00
n/a
8
Nov ’25
₹1,154.75
₹936.38
-18.9%
9.5%
₹1,070.00
₹820.00
n/a
8
Oct ’25
₹1,132.60
₹891.88
-21.3%
9.7%
₹990.00
₹745.00
n/a
8
Sep ’25
₹1,082.65
₹891.88
-17.6%
9.7%
₹990.00
₹745.00
n/a
8
Aug ’25
₹1,103.75
₹888.25
-19.5%
9.4%
₹1,000.00
₹780.00
n/a
8
Jul ’25
₹1,107.35
₹887.00
-19.9%
8.9%
₹990.00
₹780.00
n/a
8
Jun ’25
₹1,030.15
₹892.75
-13.3%
8.8%
₹985.00
₹770.00
n/a
8
May ’25
₹1,072.15
₹878.88
-18.0%
8.2%
₹985.00
₹770.00
n/a
8
Apr ’25
₹1,087.20
₹865.00
-20.4%
8.2%
₹1,010.00
₹780.00
n/a
8
Mar ’25
₹968.00
₹844.29
-12.8%
5.6%
₹904.00
₹780.00
n/a
7
Feb ’25
₹1,014.90
₹961.14
-5.3%
11.6%
₹1,140.00
₹790.00
n/a
7
Jan ’25
₹1,117.85
₹941.14
-15.8%
11.1%
₹1,140.00
₹790.00
n/a
7
Dec ’24
₹969.95
₹964.75
-0.5%
12.0%
₹1,140.00
₹790.00
n/a
8
Nov ’24
₹950.35
₹1,032.86
+8.7%
7.9%
₹1,140.00
₹912.00
₹1,154.75
7
Oct ’24
₹1,031.20
₹1,025.71
-0.5%
7.2%
₹1,130.00
₹912.00
₹1,132.60
7
Sep ’24
₹1,071.15
₹1,009.71
-5.7%
8.2%
₹1,130.00
₹912.00
₹1,082.65
7
Aug ’24
₹1,072.90
₹1,062.29
-1.0%
7.3%
₹1,150.00
₹916.00
₹1,103.75
7
Jul ’24
₹1,001.40
₹1,066.57
+6.5%
7.5%
₹1,150.00
₹916.00
₹1,107.35
7
Jun ’24
₹968.95
₹1,108.14
+14.4%
5.2%
₹1,192.00
₹995.00
₹1,030.15
7
May ’24
₹952.70
₹1,123.14
+17.9%
8.7%
₹1,250.00
₹1,010.00
₹1,072.15
7
Apr ’24
₹972.45
₹1,126.00
+15.8%
9.0%
₹1,270.00
₹1,010.00
₹1,087.20
7
Mar ’24
₹994.50
₹1,138.29
+14.5%
10.0%
₹1,278.00
₹1,010.00
₹968.00
7
Feb ’24
₹956.15
₹1,175.00
+22.9%
10.2%
₹1,345.00
₹1,022.00
₹1,014.90
7
Jan ’24
₹937.15
₹1,238.57
+32.2%
7.9%
₹1,345.00
₹1,022.00
₹1,117.85
7
Dec ’23
₹1,048.70
₹1,274.67
+21.5%
3.5%
₹1,345.00
₹1,200.00
₹969.95
6
Nov ’23
₹1,142.20
₹1,269.29
+11.1%
4.2%
₹1,345.00
₹1,196.00
₹950.35
7
Analyst Forecast: Target price is lower than the current share price.